Pseudomonas aeruginosa Scleritis following Pterygium Surgery with Mitomycin C or Beta Irradiation: Three-Case Report

Table 1

Demographics, clinical characteristics, treatments, and outcomes of three cases with Pseudomonas aeruginosa scleritis.

Case	Sex/age (yr)/eye	Adjunctive therapy	Latent period (yr)	Associated risk factors	BCVA initial-final	Clinical features	Treatments	Additional procedures
1	M/67/OD	Mitomycin C	12	None	6/36-6/12	Scleral thinning surrounded by edematous necrotic tissue	Fortified amikacin eye drops and intravenous ceftazidime	Superficial necrotic scleral debridement
2	F/68/OD	Mitomycin C	5	None	6/18-6/6	Necrotic scleral ulcer with severe mucopurulent discharge	Fortified gentamicin and cefazolin and intravenous amikacin and ceftazidime	Superficial necrotic scleral debridement
3	M/70/OD	Beta irradiation	25	Diabetes mellitus	Hm	Severe lids swelling, marked chemosis, scleral ulcer with calcium plaques	Fortified gentamicin and cefazolin and intravenous amikacin and ceftazidime	Vitreous tapping with intravitreal antibiotics injection and scleral debridement with ceftazidime irrigation; Enucleation

BCVA: best-corrected visual acuity; F: female; Hm: hand movement; M: male; OD: right eye; yr: year.